Price
CHART BY
Data
TER
- 0.75%
Fund Volume
- $1.34B
Asset Class
- Equity
Distributing
- Yes
Replication Method
- Physical Full
Region
- Global
Country Based
- USA
Issuer
- ARK
Industry Breakdown
- Biotechnology45.77%
- Medical Specialties19.76%
- Packaged Software12.91%
- Medical/ Nursing Services12.63%
- Major Pharmaceuticals8.88%
- Not Classified0.05%
Sector Breakdown
- Health Care99.95%
- Other0.05%
Region Breakdown
🇺🇸
USA90.13%🇨🇭
Switzerland7.85%🇬🇧
United Kingdom1.01%🇳🇱
Netherlands0.97%🏳️
Other0.05%
Frequently asked questions
What is the Total Expense Ratio (TER) of ARK Genomic Revolution ETF?
The total expense ratio (TER) of ARK Genomic Revolution ETF is 0.75%. The TER represents the annual fees charged by the ETF provider, covering management costs and operational expenses. A lower TER can enhance your investment returns over time.
What is the fund volume of ARK Genomic Revolution ETF?
ARK Genomic Revolution ETF has a fund volume of $1.34B. Fund volume indicates the total assets under management (AUM) and reflects the ETF's size and liquidity. Larger fund volumes generally offer better liquidity and tighter bid-ask spreads.
Is ARK Genomic Revolution ETF paying dividends?
ARK Genomic Revolution ETF is a Distributing ETF. It distributes dividends to investors. The last payment was 31.12.2021, with an amount of $0.38.
What is the replication method used by ARK Genomic Revolution ETF?
ARK Genomic Revolution ETF uses a physical full replication method. In this approach, the ETF purchases all the securities in the underlying index in the exact proportions as the index. This ensures the most precise tracking of the index's performance since the ETF's holdings mirror the index completely.
In which country is ARK Genomic Revolution ETF domiciled?
ARK Genomic Revolution ETF is domiciled in USA. The domicile country can affect tax implications and regulatory oversight, which may influence your investment decisions.
Pricing
- 1D span
- $30.79$32.01
- 52W span
- $17.55$34.05
Information
ARKG is an actively managed fund that targets companies involved in the genomics industry.
Identifier
- Primary Ticker
- ARKG
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet
